Novo Nordisk (NVO) vs. Eli Lilly (LLY)
Side-by-side institutional breakdown evaluating fundamental balance sheet health, growth trajectory, Piotroski F-Scores, and volatility invalidation levels.
Launch Live Interactive Comparison Matrix
Filter by Day Trader scalping metrics, macro correlation coefficients, and institutional holdings.
Quantitative Scorecard Comparison
| Metric / Factor | NVO (Novo Nordisk) | LLY (Eli Lilly) |
|---|---|---|
| Current Spot Price | $138.50 | $920.40 |
| Composite Factor Score | 88 / 100 | 86 / 100 |
| Piotroski 9-Point F-Score | 8 / 9 | 7 / 9 |
| Growth Score | 89 / 100 | 92 / 100 |
| Quality Score | 94 / 100 | 91 / 100 |
| Valuation Score | 74 / 100 | 65 / 100 |
| Institutional Verdict | High Quality Compounder | Secular Pharma Leader |